Achieve Life Sciences (ACHV) Change in Acquisitions & Divestments (2010 - 2026)

Achieve Life Sciences has disclosed Change in Acquisitions & Divestments across 12 years of filings, most recently posting $15.4 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 4.87% year-over-year to $15.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.6 million (up 15.42% YoY) and the FY2025 annual result came in at $30.9 million, up 17.33% from the prior year.
• Change in Acquisitions & Divestments improved to $15.4 million in Q1 2026, from $5.8 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $15.4 million in Q1 2026 and troughed at $2.8 million in Q3 2025.
• A 3-year average of $9.8 million and a median of $10.1 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments sank 54.14% — and 2026, when it gained 4.87%.
• Tracing ACHV's Change in Acquisitions & Divestments over 3 years: stood at $12.6 million in 2024, then plunged by 54.14% to $5.8 million in 2025, then jumped by 166.07% to $15.4 million in 2026.
• Business Quant data shows ACHV's Change in Acquisitions & Divestments at $15.4 million in Q1 2026, $5.8 million in Q4 2025, and $2.8 million in Q3 2025.